We quantitatively and qualitatively investigated 2-dimensional (2D) and 3-dimensional (3D) imaging with scan-time reduction in 14 patients with 17 lesions, who had known or suspected head and neck cancer, using a bismuth germanate (BGO) crystal based PET/CT scanner with noise-matched images. Methods: A 2D and 3D acquisition protocol using scan-time reduction on an axial single field of view resulted in a 2D 4-, 3D 4-, 3D 3-, 2D 3-, 2D 2-, and 3D 2-min scan sequence to minimize redistribution and decay bias. Tumor maximum standardized uptake values (SUVmax) and tumor mean standardized uptake values (SUV mean ) were recorded, and two observers in consensus investigated lesion conspicuity between 2D and 3D paired 4-, 3-, and 2-min noisematched images. Results: We found some minor advantages quantitatively in favor of 2D scanning, with higher mean SUVmax, and qualitatively in favor of 3D scanning, with lesion conspicuity preference. In our cohort, no great advantage or disadvantage to using either acquisition mode was observed, and all lesions were seen irrespective of acquisition mode and scan time. Conclusion: In head and neck cancer patients, we can recommend a scan-time reduction from 4 to 3 min/bed position in 2D acquisitions with a BGO-based PET/CT scanner, using our imaging protocol and reconstruction defaults. Bi smuth germanate (BGO) crystal-based PET and more recent combined PET/CT scanners are in widespread clinical use, predominantly to image 18 F-FDG in cancer studies, but there is still controversy over potential advantages or disadvantages of 2-dimensional (2D) versus 3-dimensional (3D) acquisition and scan-time reduction clinically. In 2D scanning, interplane septa reduce image-degrading random and scattered counts at the expense of overall system sensitivity, with the possibility of long scan times to improve count statistics. In 3D scanning, septa are retracted (typically allowing a large increase in such counts), thereby requiring imaging systems with characteristics of low dead time, fast decay crystal or readout electronics, good energy resolution, and scatter correction to optimize the signal-to-noise ratio in images.Such factors raise questions about the clinical advantages and disadvantages of 2D acquisition, compared with 3D acquisition (1), regarding image quality and potential scantime and dose reduction. Additional parameters that may influence this comparison are patient demographics, fasting time before scanning, choice and amount of tracer administered, time to start scanning after injection, data representation and reconstruction algorithms used (2), scanner used (3), and type or site of cancer.Phantom studies have been used to investigate the lesionto-background ratios for 2D and 3D acquisition modes in whole-body (WB) scanning. In 1 phantom study, injected activity was optimized using 2D and 3D noise equivalent counting (NEC) rates, but no advantage was seen (4). Similarly, no improvement was found between scanning modes in a small tumor or lymph node phantom study (5). However, 3D ...